Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
Elevated estrogen levels associated with more severe disease in scleroderma

Elevated estrogen levels associated with more severe disease in scleroderma

Newly identified internal regulator helps control body's response to fight infection

Newly identified internal regulator helps control body's response to fight infection

Finding potential treatments for autoimmune diseases

Finding potential treatments for autoimmune diseases

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

Suppressing cancer-causing protein could correct increased fibrosis in scleroderma patients

MUSC researchers identify potential therapeutic target for lung fibrosis

MUSC researchers identify potential therapeutic target for lung fibrosis

Silicone breast implants may increase risk of rare adverse outcomes in women

Silicone breast implants may increase risk of rare adverse outcomes in women

Study shows B cells could play reciprocal roles in pathogenesis of systemic sclerosis

Study shows B cells could play reciprocal roles in pathogenesis of systemic sclerosis

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Seeking solutions to treat scleroderma

Seeking solutions to treat scleroderma

Researchers find experimental compound to treat fibrotic diseases

Researchers find experimental compound to treat fibrotic diseases

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Improving the Diagnosis of Cardiac Sarcoidosis

Improving the Diagnosis of Cardiac Sarcoidosis

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Study uncovers mechanism causing chronic GVHD after bone marrow transplant

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

Report highlights needs, experiences of people with rare autoimmune rheumatic diseases

ACR receives grant to focus on projects that reduce health disparities

ACR receives grant to focus on projects that reduce health disparities

Study reveals key role of macrophages in systemic sclerosis

Study reveals key role of macrophages in systemic sclerosis

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

LJI study reveals key player that promotes skin inflammation in atopic dermatitis

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

Stem cell transplant can effectively treat patients with rare autoimmune disease, study shows

New HSS study may signal hope for patients suffering from scleroderma

New HSS study may signal hope for patients suffering from scleroderma

Stem cell transplant improves survival among scleroderma patients

Stem cell transplant improves survival among scleroderma patients